Narciclasine targets STAT3 via distinct mechanisms in tamoxifen-resistant breast cancer cells.
Lv C, Huang Y, Huang R, Wang Q, Zhang H, Jin J, Lu D, Zhou Y, Shen Y, Zhang W, Luan X, Liu S.
Lv C, et al. Among authors: wang q.
Mol Ther Oncolytics. 2022 Jan 3;24:340-354. doi: 10.1016/j.omto.2021.12.025. eCollection 2022 Mar 17.
Mol Ther Oncolytics. 2022.
PMID: 35118192
Free PMC article.